We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Following Face Transplantation Surgery, Blood Vessels Shown to Reorganize

By HospiMedica International staff writers
Posted on 24 Dec 2013
In face transplant recipients, new findings have shown that blood vessels reorganize themselves, leading to a better determination of the biologic alterations that occur after full-face transplantation. More...


The study’s findings were presented December 2013 at the annual meeting of the Radiological Society of North America (RSNA) held in Chicago (IL, USA). Face transplantation is a recent development in reconstructive surgery for patients who have lost some or all of their face from injury or disease. The first full face transplantation in the United States was performed at Brigham and Women’s Hospital (BGH; Boston, MA, USA) in 2011. Hospital specialists next performed full-face transplantations on three additional patients.

Surgeons, during the procedure, connect the patient’s major arteries and veins to those from a donor face (called a facial allograft) to safeguard healthy circulation in the transplanted tissue. Because the technology is new, not much is known about the vascular changes that help blood perfuse into the transplanted tissue. The development of new blood vessel networks in transplanted tissue is critical to the success of face transplant surgery.

“All three patients included in this study at Brigham and Women's maintain excellent perfusion, or blood flow, the key element of viability of the facial tissues and the restoration of form and function to those individuals who otherwise had no face,” said study co-uthor Frank J. Rybicki, MD, PhD, FAHA, FACR, director of BGH’s Applied Imaging Science Laboratory. “We assumed that the arterial blood supply and venous blood return was simply from the connections of the arteries and the veins at the time of the surgery.”

Dr. Rybicki and Kanako K. Kumamaru, MD, PhD, research fellow at Brigham and Women’s Applied Imaging Science Laboratory, used 320-detector row dynamic computed tomography angiography (CTA) to examine the facial allografts of the three patients one year after successful transplantation. The CTA technology offers imaging over 16 cm of coverage, enabling the researchers to view collateralization, a process in which the body stimulates existing blood vessels to elongate, widen, and form new connections. Collateralization frequently results from anastomoses. “The key finding of this study is that, after full face transplantation, there is a consistent, extensive vascular reorganization that works in concert with the larger vessels that are connected at the time of surgery,” Dr. Kumamaru said.

The findings revealed that the new blood vessel networks course posteriorly, or toward the ears and even farther behind the head, in addition to the large arteries and veins that course anteriorly in the face, or close to the jaw. “We have found that since the vessels more commonly associated with the back of the head are critical to maintain the perfusion via vascular reorganization, it is essential to visualize these vessels and determine that they are normal preoperatively,” Dr. Kumamaru said. “Patients under consideration for face transplantation have universally had some catastrophic defect or injury.”

The investigators noted that the findings could help enhance surgical planning and evaluation of potential complications in face transplant patients. For instance, earlier published studies recommended the joining of multiple arteries and veins to provide sufficient blood flow in the facial allograft. However, performing these multiple connections causes longer operation time compared with a single anastomosis.

“Our findings support the simplified anastomosis for full face transplant procedure that, in turn, can potentially shorten the operative time and reduce procedure-associated complications,” Dr. Rybicki concluded.

Related Links:

Brigham and Women’s Hospital



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.